liposomal glutathione bioavailability clinical trials review Oral delivery of glutathione: antioxidant function, barriers and strategies – ScienceOpen Liposomal glutathione outperforms plain glutathione

The American Diabetes Association's 2024 Standards of Care in Diabetes note that alpha-lipoic acid has been studied for diabetic neuropathy but that "glycemic monitoring should be considered when initiating antioxidant supplements with known insulin-sensitizing activity in patients on pharmacologic glucose-lowering therapy" [13]

There is no published, peer-reviewed, full-paper randomised human trial with accessible results showing that BPC-157 is effective or safe for any indication

Getting enough rest and recovery can make a big difference

It is one of the twelve peptides the FDA removed from the list that restricted compounding in April 2026, and one of seven under formal advisory review on July 2324, 2026